HMC Capital Ltd (ASX: HMC) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

HMC Capital Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $1.02 billion
P/E Ratio 8.52
Dividend Yield 4.69%
Shares Outstanding 412.62 million
Earnings per share -0.324
Dividend per share 0.12
Year To Date Return -33.84%
Earnings Yield 11.74%
Franking 16.6666666667
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

HMC Capital Ltd (ASX: HMC)
Latest News

Young businessman standing on the top of the mountain punching fist in the air.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX 200 finished Friday's session just 1% lower than its all-time record high.

Read more »

Two male ASX 200 analysts stand in an office looking at various computer screens showing share prices
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers are bullish on these ASX shares...

Read more »

A man in his office leans back in his chair with his hands behind his head looking out his window at the city, sitting back and relaxed, confident in his ASX share investments for the long term.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers are bullish on these ASX shares...

Read more »

A male ASX 200 broker wearing a blue shirt and black tie holds one hand to his chin with the other arm crossed across his body as he watches stock prices on a digital screen while deep in thought
Share Market News

5 things to watch on the ASX 200 on Monday

Here's what to expect on the ASX 200 on Monday...

Read more »

A woman inflates a balloon with the word 'sale' on it.
Ask a Fund Manager

40% sale! 2 cheap ASX shares to buy for a better 2023: fundie

Ask A Fund Manager: Tribeca Investment's Simon Brown loves this pair of stocks for what could be a massive year…

Read more »

trophy depicting top 10, asx 200 shares
Share Market News

Here are the top 10 ASX 200 shares today

These ASX 200 shares outperformed the index on Monday.

Read more »

A male sharemarket analyst sits at his desk looking intently at his laptop with two other monitors next to him showing stock price movements
Share Market News

5 things to watch on the ASX 200 on Friday

The ASX 200 looks set to end the week in the red...

Read more »

Dividend Payment History Data provided by Morningstar.

Data provided by Morningstar.
Ex-Date Amount Franking Type Payable
03 Mar 2026 $0.0600 16.67% Interim 09 Apr 2026
26 Aug 2025 $0.0600 0.00% Final 30 Sep 2025
25 Feb 2025 $0.0600 100.00% Interim 01 Apr 2025
27 Aug 2024 $0.0600 70.00% Final 02 Oct 2024
26 Feb 2024 $0.0600 0.00% Interim 02 Apr 2024
29 Aug 2023 $0.0600 10.00% Final 04 Oct 2023
01 Mar 2023 $0.0600 100.00% Interim 06 Apr 2023
01 Sep 2022 $0.0600 100.00% Final 07 Oct 2022
01 Mar 2022 $0.0600 100.00% Interim 07 Apr 2022
02 Sep 2021 $0.0600 50.00% Final 01 Oct 2021
02 Mar 2021 $0.0600 100.00% Interim 17 Mar 2021
03 Sep 2020 $0.0750 100.00% Final 18 Sep 2020
04 Mar 2020 $0.0450 100.00% Interim 19 Mar 2020

HMC ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
YesNo

About HMC Capital Ltd

HMC Capital Ltd is a property group focused on ownership, development, and management. The company's operating segment includes Real Estate which comprises of HMC Capital managed HomeCo Daily Needs REIT, HealthCo Healthcare and Wellness REIT, HMC Wholesale Healthcare Fund and the Last Mile Logistics Fund; Private Equity which includes the HMC Capital Partners Fund I, a high conviction strategic stakes fund; and Corporate properties which includes unallocated costs and Capital Solutions activities which includes short term investments undertaken relating to non-HMC managed funds. It generates maximum revenue from the Real Estate segment. The company portfolio comprises mainly retail and services centers.

HMC Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
05 Mar 2026 $2.46 $0.05 2.07% 3,121,862 $2.51 $2.52 $2.41
04 Mar 2026 $2.41 $-0.15 -5.86% 4,156,147 $2.54 $2.57 $2.40
03 Mar 2026 $2.56 $-0.14 -5.19% 4,023,196 $2.68 $2.74 $2.54
02 Mar 2026 $2.70 $-0.08 -2.88% 3,283,650 $2.70 $2.74 $2.64
27 Feb 2026 $2.78 $-0.12 -4.14% 2,990,017 $2.90 $2.90 $2.77
26 Feb 2026 $2.90 $0.09 3.20% 4,007,151 $2.84 $2.92 $2.78
25 Feb 2026 $2.81 $-0.01 -0.35% 4,273,037 $2.80 $2.88 $2.76
24 Feb 2026 $2.82 $-0.14 -4.73% 9,351,269 $2.93 $2.93 $2.67
23 Feb 2026 $2.96 $-0.10 -3.27% 3,060,703 $3.07 $3.11 $2.96
20 Feb 2026 $3.06 $-0.07 -2.24% 2,007,927 $3.05 $3.11 $3.02
19 Feb 2026 $3.13 $-0.02 -0.63% 1,990,417 $3.15 $3.17 $3.00
18 Feb 2026 $3.15 $0.09 2.94% 3,695,288 $3.13 $3.18 $3.08
17 Feb 2026 $3.06 $-0.07 -2.24% 2,358,586 $3.09 $3.10 $3.02
16 Feb 2026 $3.13 $0.02 0.64% 2,315,451 $3.13 $3.18 $3.05
13 Feb 2026 $3.11 $-0.21 -6.33% 2,813,945 $3.29 $3.29 $3.10
12 Feb 2026 $3.32 $-0.28 -7.78% 3,089,416 $3.62 $3.63 $3.30
11 Feb 2026 $3.60 $-0.14 -3.74% 1,890,500 $3.74 $3.75 $3.59
10 Feb 2026 $3.74 $0.02 0.54% 2,450,908 $3.75 $3.91 $3.68
09 Feb 2026 $3.72 $-0.20 -5.10% 8,337,515 $4.02 $4.09 $3.69
06 Feb 2026 $3.92 $-0.11 -2.73% 14,933,436 $4.10 $4.34 $3.73
05 Feb 2026 $4.03 $0.00 0.00% 1,839,382 $4.03 $4.10 $3.98
04 Feb 2026 $4.03 $-0.22 -5.18% 1,255,497 $4.25 $4.26 $4.02
03 Feb 2026 $4.25 $0.06 1.43% 1,079,912 $4.22 $4.27 $4.13

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
25 Feb 2026 Christopher Roberts Exercise 8,560 $24,053
Conversion of securities. 8,560 rights
25 Feb 2026 Christopher Roberts Buy 8,560 $24,053
Conversion of securities.
25 Feb 2026 Gregory (Greg) Hayes Exercise 7,846 $22,047
Conversion of securities. 13,547 rights
25 Feb 2026 Gregory (Greg) Hayes Buy 7,846 $22,047
Conversion of securities.
25 Feb 2026 Fiona Pak-Poy Exercise 7,846 $22,047
Conversion of securities. 7,846 rights
25 Feb 2026 Fiona Pak-Poy Buy 7,846 $22,047
Conversion of securities.
25 Feb 2026 Christopher Saxon Exercise 17,833 $50,110
Conversion of securities. 17,833 rights
25 Feb 2026 Christopher Saxon Buy 17,833 $50,110
Conversion of securities.
25 Feb 2026 Kelly O'Dwyer Exercise 10,700 $30,067
Conversion of securities. 10,700 rights
25 Feb 2026 Kelly O'Dwyer Buy 10,700 $30,067
Conversion of securities.
25 Feb 2026 Susan Roberts Exercise 9,986 $28,060
Conversion of securities. 9,986 rights
25 Feb 2026 Susan Roberts Buy 9,986 $28,060
Conversion of securities.
27 Nov 2025 Kelly O'Dwyer Issued 21,400 $75,970
Director remuneration. 21,400 rights
27 Nov 2025 Susan Roberts Issued 19,972 $70,900
Director remuneration. 19,972 rights
27 Nov 2025 Fiona Pak-Poy Issued 15,692 $55,706
Director remuneration. 15,692 rights
27 Nov 2025 David Di Pilla Issued 595,924 $2,115,530
Issue of securities. 1,639,348 performance rights
27 Nov 2025 Christopher Saxon Issued 35,666 $126,614
Director remuneration. 35,666 rights
27 Nov 2025 Christopher Roberts Issued 17,120 $60,776
Director remuneration. 17,120 rights
27 Nov 2025 Gregory (Greg) Hayes Issued 15,692 $55,706
Director remuneration. 21,393 rights
21 Nov 2025 Kelly O'Dwyer Buy 32,959 $104,761
On-market trade. 1000 Prior Holding
30 Sep 2025 David Di Pilla Expiry 179,616 $571,178
As advised by the company. Lapsed, 10,43,424 Rights
05 Sep 2025 David Di Pilla Buy 367,783 $1,316,663
On-market trade.
04 Sep 2025 David Di Pilla Buy 200,120 $684,410
On-market trade.
20 Aug 2025 David Di Pilla Buy 1,346,181 $5,021,913
On-market trade.
20 Aug 2025 Christopher Saxon Buy 8,036 $30,938
Conversion of securities.
20 Aug 2025 Christopher Saxon Exercise 8,036 $30,938
Conversion of securities.
20 Aug 2025 Susan Roberts Exercise 4,500 $17,325
Conversion of securities.
20 Aug 2025 Susan Roberts Buy 4,500 $17,325
Conversion of securities.
20 Aug 2025 Kelly O'Dwyer Buy 4,179 $16,089
Conversion of securities.
20 Aug 2025 Kelly O'Dwyer Exercise 4,179 $16,089
Conversion of securities.
20 Aug 2025 Fiona Pak-Poy Buy 3,621 $13,940
Conversion of securities.
20 Aug 2025 Fiona Pak-Poy Exercise 3,621 $13,940
Conversion of securities.
20 Aug 2025 Gregory (Greg) Hayes Buy 3,536 $13,613
Conversion of securities.
20 Aug 2025 Gregory (Greg) Hayes Exercise 3,536 $13,613
Conversion of securities. 5,701 rights
20 Aug 2025 Christopher Roberts Exercise 3,952 $15,215
Conversion of securities.
20 Aug 2025 Christopher Roberts Buy 3,952 $15,215
Conversion of securities.
22 May 2025 David Di Pilla Sell 10,845,709 $57,048,429
As advised by the company. Distribution of shares to HICT unitholder as part of a transaction under which the unitholder redeemed their units in HICT. As per announcement on 26-05-2025
09 Apr 2025 Christopher Roberts Buy 66,812 $311,343
As advised by the company. Acquisition of fully paid ordinary shares on market.
08 Apr 2025 Christopher Roberts Buy 86,812 $410,620
As advised by the company. Acquisition of fully paid ordinary shares on market

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Dr Christopher Graham Roberts Non-Executive Director Nov 2024
Dr Roberts has over 40 years of experience in the medical device industry serving a number of senior management positions. He was the former CEO of Cochlear from 2004 to 2015 and is presently a member of the Cochlear Foundation Board, Non-Executive Director of HCW Funds Management Limited, HMC Capital Partners Fund 1, Atmo Biosciences Ltd, Centenary Institute of Medical Research and Nutromics Pty Ltd. He was also the Executive Vice President of ResMed from 1992 to 2003, and a director until 2017. He was a former Chair of Research Australia from 2004 to 2010. He is member of the risk committee.
Mr Gregory (Greg) John Hayes Non-Executive Director Sep 2019
Mr Hayes is currently a Non-Executive Director of Aurrum Holdings Pty Ltd and Secure AI Pty Ltd. Having worked across a range of industries including property, infrastructure, energy and logistics, his skills and experience include strategy, finance, mergers and acquisitions and strategic risk management, in particular in listed companies with global operations. He was previously Chief Financial Officer and Executive Director of Brambles Limited, Chief Executive Officer and Group Managing Director of Tenix Pty Ltd, Chief Financial Officer and later interim Chief Executive Officer of the Australian Gaslight Company, Chief Financial Officer Australia and New Zealand of Westfield Holdings, Executive General Manager, Finance of Southcorp Limited. He is a member of Risk Committee.
Ms Fiona Jane Pak-Poy Non-Executive Director Nov 2024
Ms Pak Poy is Non-Executive Director of Silicon Quantum Computing Pty Ltd and Kain Lawyers Pty Ltd. She is on the Board of Trustees and Investment Committee for HMC Capital Partners Fund 1 and is a member of the Business Advisory Council for Anacacia Capital. She has over 30 years of experience in a variety of industries, for companies ranging from startups to listed companies, government entities and not-for-profits. She has served on various boards, including, MYOB, Isentia, Novotech, PageUp People, StatePlus and SIRCA (the Securities Research Centre of South-East Asia). She served on the ASIC director Advisory Panel and the Board of Innovation Australia. Previously she was a strategy consultant for the Boston Consulting Group in the US and Australia and was a General Partner in an Australian venture capital fund focused on technology startups. She is Member of the Sustainability Committee.
Mr David Anthony Di Pilla Chief Executive OfficerExecutive DirectorManaging Director Oct 2017
Mr Pilla led the team that founded the consortium which led to the ultimate establishment HMC Capital in 2016. Since this time, the HMC Group has grown from its initial Masters portfolio to today being a diversified alternative asset manager. He has over 30 years of experience in investment banking, strategic advisory & consulting and corporate leadership as a Director and CEO. During his 20-year investment banking career he was Managing Director of UBS Investment Bank for over 15 years and during this time led some of Australias landmark transactions across corporate M&A, Equity & Debt Capital Markets. Prior to his time at UBS, he reached the position of Vice President, Investment Banking at JP Morgan.
Mr Christopher Saxon Non-Executive DirectorNon-Executive Chairman Sep 2019
Mr Saxon was, until 2019, a partner with global law firm Baker McKenzie. His practice included large scale mergers and acquisition transactions across a range of sectors, notably energy (gas, electricity, renewable), industrials, infrastructure and mining. He has been ranked as one of Australias foremost project and M&A lawyers and has been lead adviser on government restructuring transactions and privatisations, major trade sales and infrastructure projects. He served as Chair of Baker McKenzie Australia for five years (2012-2017) and held numerous leadership roles within the firm.
Hon Kelly Megan O'Dwyer Non-Executive Director Nov 2020
Hon O Dwyer is a Non-Executive Director of EQT Holdings Limited, HealthCo Healthcare and Wellness REIT, DigiCo Infrastructure REIT, Barrenjoey Capital Partners Group Holdings Pty Ltd and the National Reconstruction Fund Corporation. She previously served in the Australian Parliament as a Senior Cabinet Minister holding a number of key economic portfolios including Minister for Jobs and Industrial Relations; Minister for Revenue and Financial Services; Minister for Small Business; and Assistant Treasurer. She also served on the Cabinets Budget Committee (the Expenditure Review Committee) and held the portfolios of Minister for Women; as well as Minister Assisting the Prime Minister with the Public Service. Prior to entering Parliament, she worked in law, government and finance and brings insights across a range of sectors including funds management, superannuation, workplace relations, foreign investment, law and banking. She is Chair of Sustainability Committee, Member of the Risk Committee.
Ms Susan Roberts Non-Executive Director Nov 2022
Ms Roberts is an experienced director and CEO with over 30 years in the financial services, investment and insurance industries. Her current roles include Chair of Audit for AIG Australia and Teachers Health, and she is a director of Metlife Australia. She has commercial and financial executive experience, including CEO and Managing Director of Lazard Asset Management Pacific, and Director, Strategy at Lend Lease Investment Services. She has previously served as a Non-Executive Director of Maple Brown Abbott and as Chair of the Audit and Risk, and Claims Committee for Zurich Australia Superannuation. Susan was also Chair of the Investor Working Group for the 30% Club in Australia. She is Member of the Sustainability Committee.
Mr Andrew Selim Company SecretaryGeneral Counsel
-
Andrew Selim Company SecretaryGeneral Counsel
-
Will McMicking Group Chief Financial Officer
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
Hsbc Custody Nominees (Australia) Limited 138,856,111 33.98%
Home Investment Consortium Trust 79,535,204 19.47%
J P Morgan Nominees Australia Pty Limited 47,317,554 11.58%
Citicorp Nominees Pty Limited 35,847,791 8.77%
Goat Properties Pty Ltd 12,853,001 3.15%
National Nominees Limited 7,762,252 1.90%
Aurrum Holdings Pty Ltd 7,023,606 1.72%
BNP Paribas Nominees Pty Ltd 4,719,004 1.15%
Netwealth Investments Limited 4,031,608 0.99%
UBS Nominees Pty Ltd 3,280,022 0.80%
BNP Paribas Noms Pty Ltd 2,484,927 0.61%
CW Property Nominees Pty Ltd 2,238,806 0.55%
BNP Paribas Noms Pty Ltd 1 2,089,200 0.51%
Pacific Custodians Pty Limited 1,513,230 0.37%
Aldaoud Pty Ltd 1,300,000 0.32%
SG Foundation Investments Pty Ltd 1,071,014 0.26%
BNP Paribas Noms Pty Ltd 2 989,575 0.24%
HSBC Custody Nominees (Australia) Limited 1 945,553 0.23%
BNP Paribas Noms Pty Ltd 3 868,483 0.21%
Doux Argent Pty Ltd 743,301 0.18%

Profile

since

Note